technology and platforms

our projects

The project portfolio of Xlife Sciences AG is based on four pillars: technology platforms, biotech and therapies, medical technology and artificial intelligence. Our co-investors benefit from our unique selling proposition. In addition, our broad project portfolio offers adequate risk diversification.

Inventum Genetics GmbH

Technology Platforms

Inventum Genetics GmbH was incorporated in 2019 in Mainz, Germany. The company is dedicated to identify new therapeutic approaches and biomarker for common diseases based on human genetic data.

Learn more

inflamed pharma GmbH

Technology Platforms

inflamed pharma GmbH produces, researches, develops, and manufactures the chemical and active pharmaceutical ingredients applied in innovative therapies for human and veterinary medicine.

Learn more

VERAXA Biotech GmbH

Technology Platforms

Veraxa Biotech AG focuses on the development of antibody-drug conjugates through an innovative click chemistry approach and the microfluidic screening of functional antibodies.

Learn more

palleos healthcare GmbH

Technology Platforms

The palleos healthcare GmbH was incorporated in 2013 and is a full service clinical research organization ("CRO") based in Wiesbaden, Germany.

Learn more